Cargando…
Coding of Glioblastoma Progression and Therapy Resistance through Long Noncoding RNAs
Glioblastoma is the most aggressive and lethal primary brain malignancy, with an average patient survival from diagnosis of 14 months. Glioblastoma also usually progresses as a more invasive phenotype after initial treatment. A major step forward in our understanding of the nature of glioblastoma wa...
Autores principales: | Zottel, Alja, Šamec, Neja, Videtič Paska, Alja, Jovčevska, Ivana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409010/ https://www.ncbi.nlm.nih.gov/pubmed/32650527 http://dx.doi.org/10.3390/cancers12071842 |
Ejemplares similares
-
Nanomedicine and Immunotherapy: A Step Further towards Precision Medicine for Glioblastoma
por: Šamec, Neja, et al.
Publicado: (2020) -
Non-animal glioblastoma models for personalized treatment
por: Zottel, Alja, et al.
Publicado: (2023) -
Nanotechnology Meets Oncology: Nanomaterials in Brain Cancer Research, Diagnosis and Therapy
por: Zottel, Alja, et al.
Publicado: (2019) -
Sonication is a suitable method for loading nanobody into glioblastoma small extracellular vesicles
por: Colja, Sara, et al.
Publicado: (2023) -
Dynamic Intercell Communication between Glioblastoma and Microenvironment through Extracellular Vesicles
por: Krapež, Gloria, et al.
Publicado: (2022)